CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), announced today that it is transforming the Company to focus exclusively on the commercialization and development of Abecma ...

2seventy's Q3, 10-Q (the "10-Q") addresses its Regeneron (REGN) deal at several locations. It characterizes the deal as a key component of its strategic realignment so it can focus on the ...

(Reuters) -2seventy bio said on Tuesday it plans to lay off about 40% of its workforce to lower costs and focus on the biotech firm's cancer cell therapy Abecma, lifting the company's shares more ...

On Thursday, 2seventy Bio Inc. TSVT completed the asset purchase agreement with Novo Nordisk A/S NVO. Under the terms, Novo Nordisk has acquired the Hemophilia A program and rights to 2seventy’s ...

2seventy bio (TSVT) has taken a new strategic route, narrowing its focus squarely on ABECMA, their CAR-T cell therapy developed in collaboration with Bristol Myers Squibb (BMY).

2seventy’s renewed Abecma push comes as the med’s CAR-T rival—Johnson & Johnson and Legend Biotech's Carvykti—is gaining momentum thanks to its perceived better clinical data.

In September, 2seventy said it plans to cut 40% of its workforce to lower costs and focus on its cancer cell therapy Abecma, for which it has partnered with Bristol Myers Squibb BMY.N.

Fintel reports that on August 15, 2023, Goldman Sachs maintained coverage of 2seventy bio (NASDAQ:TSVT) with a Buy recommendation. As of August 2, 2023, the average one-year price target for ...

Guggenheim Partners downgraded 2seventy Bio Inc (NASDAQ:TSVT) to Neutral from Buy and removed the price target. On Tuesday, 2seventy Bio announced restructuring its business operations and ...

2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday ...

Yaron Werber has given his Hold rating due to a combination of factors affecting 2seventy bio’s stock. Despite the recognition of a modest increase in Q2 sales and evidence of growing demand for ...